Loading clinical trials...
Loading clinical trials...
Prospective Non-randomized Single Arm Multi-center Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65 (RESILIENCE Trial)
Conditions
Interventions
Subjects previously implanted with a RESILIA aortic tissue valve.
Locations
10
United States
University of Southern California
Los Angeles, California, United States
University of Florida - Shands Hospital
Gainesville, Florida, United States
University of Maryland, Baltimore
Baltimore, Maryland, United States
Columbia University Medical Center-NY Presbyterian Hospital
New York, New York, United States
Weill Cornell - NYC
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Start Date
November 5, 2018
Primary Completion Date
February 13, 2024
Completion Date
February 13, 2024
Last Updated
May 9, 2024
NCT06518317
NCT04139616
NCT05202977
NCT07411768
NCT06106451
NCT04870424
Lead Sponsor
Edwards Lifesciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions